Chinese english Germany Japanese Korea

1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI)

1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI) Struktur
454685-88-2
CAS-Nr.
454685-88-2
Englisch Name:
1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI)
Synonyma:
7H-Pyrrolo[2,3-d]pyriMidine-5-carbonitrile;1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI)
CBNumber:
CB71080947
Summenformel:
C7H4N4
Molgewicht:
144.13
MOL-Datei:
454685-88-2.mol
Request For Quotation

1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI) Eigenschaften

storage temp. 
2-8°C

Sicherheit

1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 15)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou MolCore BioPharmatech Co.,Ltd. 		+86-057181025280; +8617767106207
 sales@molcore.com China 49739 58
BePharm Ltd 400-685-9117
market@bepharm.com China 15081 60
Aikon International Limited 025-66028182 18112977050
 cfzhang@aikonchem.com China 15820 58
Nanjing SynTitan Pharmaceutical Co., Ltd. 25-57027686 17372956142
 li_lan@syntitan.com China 7946 58
Shanghai Baoyisheng Biotechnology Co., LTD 15221020695
502277408@qq.com China 471 58
Chengdu Feibai Pharmaceutical Co., Ltd. 028-84641798 18782128315
 3302391190@qq.com China 9887 55
Changzhou ruiqing medical technology co., LTD 15380475813
 sales@ruiqingchem.com China 489 58
Accela ChemBio Co.,Ltd. 021-50795510 4000665055
 sales@accelachem.com China 11728 58
Shanghai Haohong Scientific Co., Ltd. 400-400-8210725
malulu@leyan.com China 40041 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 13327728092
 gao_ning@pharmablock.com China 9699 58
  • 1H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile (9CI)
  • 7H-Pyrrolo[2,3-d]pyriMidine-5-carbonitrile
  • 454685-88-2
  • PYRIMIDINE
Copyright 2019 © ChemicalBook. All rights reserved